Clinical Trial Update: Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib [NA]

View source ↗

Summary

A clinical trial is evaluating palbociclib as a backline treatment for advanced hepatocellular carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: RECRUITING